- Home
- RNAZ vs YMAT Comparison
RNAZ vs YMAT Comparison
Compare RNAZ & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAZ | YMAT |
|---|---|---|
| Founded | 2016 | 1970 |
| Country | United States | Taiwan |
| Employees | N/A | 65 |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 9.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNAZ | YMAT |
|---|---|---|
| Price | $5.95 | $1.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.9K | ★ 543.3K |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.82 | $0.24 |
| 52 Week High | $20.99 | $6.45 |
Technical Indicators
Market Signals| Indicator | RNAZ | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 56.82 |
| Support Level | $6.08 | $0.33 |
| Resistance Level | $9.93 | $2.47 |
| Average True Range (ATR) | 1.08 | 0.30 |
| MACD | -0.20 | 0.03 |
| Stochastic Oscillator | 8.26 | 56.30 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.